TY  - GEN
AU  - Dailey,G E
TI  - Empagliflozin: a new treatment option for patients with type 2 diabetes mellitus
SN  - 1699-3993
PY  - 2015///1216
KW  - Animals
KW  - Benzhydryl Compounds
KW  - adverse effects
KW  - Biomarkers
KW  - blood
KW  - Blood Glucose
KW  - drug effects
KW  - Diabetes Mellitus, Type 2
KW  - Glucosides
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Kidney Tubules, Proximal
KW  - Renal Elimination
KW  - Sodium-Glucose Transporter 2
KW  - metabolism
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1358/dot.2015.51.9.2368554
ER  -